We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

129 hedge funds and large institutions have $522M invested in Amphastar Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 42 increasing their positions, 53 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $489M → $522M (+$33.5M)

0.4% less ownership

Funds ownership: 55.13% → 54.73% (-0.4%)

5% less funds holding

Funds holding: 136 → 129 (-7)

21% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 53

44% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 16

Holders
129
Holders Change
-7
Holders Change %
-5.15%
% of All Funds
2.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
42
Reduced
53
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Federated Hermes
Federated Hermes
Pennsylvania
+$9.45M
2
BlackRock
BlackRock
New York
+$4.69M
3
Morgan Stanley
Morgan Stanley
New York
+$4.57M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.33M
5
Prudential Financial
Prudential Financial
New Jersey
+$1.18M

Top Sellers

1
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$5.28M
2
Two Sigma Investments
Two Sigma Investments
New York
-$3.54M
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$2.36M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$2.25M
5
AL
AJO LP
Pennsylvania
-$2.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$144M +$4.69M +240,777 +3%
Federated Hermes
2
Federated Hermes
Pennsylvania
$64.9M +$9.45M +485,525 +18%
Vanguard Group
3
Vanguard Group
Pennsylvania
$49.8M +$1.33M +68,253 +3%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$36.3M -$362K -18,608 -1%
Invesco
5
Invesco
Georgia
$28.1M +$869K +44,630 +3%
State Street
6
State Street
Massachusetts
$25.8M -$143K -7,326 -0.6%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$11.5M +$620K +31,877 +6%
Goldman Sachs
8
Goldman Sachs
New York
$11.1M +$266K +13,691 +3%
Fuller & Thaler Asset Management
9
Fuller & Thaler Asset Management
California
$11M -$5.28M -271,171 -33%
Northern Trust
10
Northern Trust
Illinois
$9.84M -$421K -21,657 -4%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$7.77M +$6.36K +327 +0.1%
SAM
12
Silvercrest Asset Management
New York
$6.69M +$1.01M +51,817 +18%
Morgan Stanley
13
Morgan Stanley
New York
$6.68M +$4.57M +235,070 +243%
Renaissance Technologies
14
Renaissance Technologies
New York
$6.29M -$1.28M -65,700 -17%
EAM
15
Eagle Asset Management
Florida
$6.28M +$548K +28,179 +10%
Prudential Financial
16
Prudential Financial
New Jersey
$5.81M +$1.18M +60,640 +27%
Nordea Investment Management
17
Nordea Investment Management
Sweden
$5.24M -$114K -5,861 -2%
Principal Financial Group
18
Principal Financial Group
Iowa
$5.06M -$193K -9,909 -4%
Charles Schwab
19
Charles Schwab
California
$4.87M +$97.6K +5,016 +2%
RCAMU
20
Rothschild & Co Asset Management US
Connecticut
$4.52M -$369K -18,963 -8%
Ameriprise
21
Ameriprise
Minnesota
$3.78M -$1.53M -78,876 -30%
N
22
Nuveen
North Carolina
$3.75M -$362K -18,626 -9%
Wells Fargo
23
Wells Fargo
California
$3.62M -$570K -29,304 -14%
Millennium Management
24
Millennium Management
New York
$3.61M +$1.02M +52,228 +41%
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$2.7M -$561K -28,811 -18%
1
2 3 4 5

AMPH Hedge Fund Activity: Q4 2020 in Review

129 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q4 2020, worth a combined $522M — up 6.9% from $489M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of AMPH and 9 opened new positions — a net loss of 7 holders — while 53 trimmed existing stakes and 42 added.

The largest buyer was Federated Hermes, adding an estimated $9.45M. The largest seller was Fuller & Thaler Asset Management, cutting an estimated $5.28M.

  • 129 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q4 2020, down from 136 in Q3 2020.
  • Funds reported $522M of Amphastar Pharmaceuticals stock for Q4 2020, up 6.9% quarter-over-quarter.
  • 9 funds opened new Amphastar Pharmaceuticals positions in Q4 2020 and 16 closed out, a net change of -7 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q4 2020 was Federated Hermes, an estimated $9.45M added.
  • The largest Amphastar Pharmaceuticals seller in Q4 2020 was Fuller & Thaler Asset Management, an estimated $5.28M sold.

Based on aggregated 13F filings for Q4 2020.